Also trades as: 0A8E.L (LSE) · $vol 0M
XERS Smart Money
Xeris Biopharma Holdings, Inc.
1W: -6.1%
1M: +6.3%
3M: +24.7%
YTD: +42.2%
1Y: +13.5%
3Y: +500.6%
5Y: +435.9%
$10.45
+0.24 (+2.35%)
Weekly Expected Move ±9.7%
$8
$9
$10
$11
$12
Credit Risk of going bust: higher than 52% of companies Debt: 13.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.19 (down 98%), Xeris Biopharma Holdings, Inc. would be worth roughly what it owes.
Total debt $289.4M against a stock market value of $1.91B.
Distance to default 4.90 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $158.2M (short-term plus half of long-term), stock volatility 54.6%; Altman Z'' -4.14. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.19 (down 98%), Xeris Biopharma Holdings, Inc. would be worth roughly what it owes.
Total debt $289.4M against a stock market value of $1.91B.
Distance to default 4.90 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $158.2M (short-term plus half of long-term), stock volatility 54.6%; Altman Z'' -4.14. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026268
Institutions Holding
+1 vs prior
45.4%
Ownership
+13.41%
38
New
105
Increased
91
Reduced
26
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Hecht Beth | officer: see remarks | S-Sale | 16,666 | $9.41 | $157K | Filing |
| 2026-10-01 | McCulloch Kevin | officer: see remarks | S-Sale | 15,000 | $9.41 | $141K | Filing |
| 2026-10-01 | Pieper Steven | officer: see remarks | S-Sale | 5,000 | $9.41 | $47K | Filing |
| 2026-09-28 | McCulloch Kevin | officer: see remarks | S-Sale | 25,000 | $10.00 | $250K | Filing |
| 2026-09-01 | Pieper Steven | officer: see remarks | S-Sale | 5,000 | $8.50 | $42K | Filing |
| 2026-09-01 | Hecht Beth | officer: see remarks | S-Sale | 16,666 | $8.49 | $141K | Filing |
| 2026-09-01 | McCulloch Kevin | officer: see remarks | S-Sale | 15,000 | $8.49 | $127K | Filing |
| 2026-08-12 | Pieper Steven | officer: see remarks | S-Sale | 5,000 | $8.50 | $42K | Filing |
| 2026-08-03 | McCulloch Kevin | officer: see remarks | S-Sale | 15,000 | $8.02 | $120K | Filing |
| 2026-08-03 | Hecht Beth | officer: see remarks | S-Sale | 16,666 | $8.01 | $134K | Filing |
| 2026-08-01 | McCulloch Kevin | officer: see remarks | F-Tax Withholding | 21,918 | $8.08 | $177K | Filing |
| 2026-08-01 | Shannon John Patrick Jr | officer: see remarks | F-Tax Withholding | 36,645 | $8.08 | $296K | Filing |
| 2026-07-07 | Pieper Steven | officer: see remarks | S-Sale | 27,600 | $8.52 | $235K | Filing |
| 2026-07-06 | Pieper Steven | officer: see remarks | S-Sale | 17,400 | $8.50 | $148K | Filing |
| 2026-07-01 | KREHER NERISSA | director | A-Grant/Award | 33,582 | $— | $0 | Filing |
| 2026-07-01 | Hecht Beth | officer: see remarks | S-Sale | 16,666 | $8.03 | $134K | Filing |
| 2026-07-01 | McCulloch Kevin | officer: see remarks | S-Sale | 90,000 | $8.03 | $723K | Filing |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | director | S-Sale | 16,000 | $6.09 | $98K | Filing |
| 2026-06-04 | Kong Garheng | director | A-Grant/Award | 24,193 | $— | $0 | Filing |
| 2026-06-04 | PERSKY MARLA | director | A-Grant/Award | 24,193 | $— | $0 | Filing |
| 2026-06-04 | Brady James Aloysius | director | A-Grant/Award | 24,193 | $— | $0 | Filing |
| 2026-06-04 | JOHNSON JOHN | director | A-Grant/Award | 24,193 | $— | $0 | Filing |
| 2026-06-04 | JOHNSON JOHN | director | S-Sale | 15,000 | $6.09 | $91K | Filing |
| 2026-06-04 | HALKUFF DAWN | director | A-Grant/Award | 24,193 | $— | $0 | Filing |
| 2026-06-04 | HALKUFF DAWN | director | S-Sale | 20,000 | $6.09 | $122K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14,525,539 | $115M | +1,579,754 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 7,804,758 | $62M | +15,947 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,340,229 | $58M | +359,347 | 2026-06-30 | Filing |
| STATE STREET CORP | 4,821,566 | $38M | +163,392 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 4,718,183 | $37M | +427,554 | 2026-06-30 | Filing |
| Nuveen, LLC | 4,385,141 | $35M | +1,468,543 | 2026-06-30 | Filing |
| Rosalind Advisors, Inc. | 2,908,981 | $23M | -322,719 | 2026-06-30 | Filing |
| Qube Research & Technologies Ltd | 2,893,749 | $23M | -1,220,676 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,626,208 | $21M | -39,400 | 2026-06-30 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2,365,103 | $19M | +193,749 | 2026-06-30 | Filing |
| MORGAN STANLEY | 2,337,096 | $19M | -235,558 | 2026-06-30 | Filing |
| Legal & General Group Plc | 2,012,792 | $16M | +104,503 | 2026-06-30 | Filing |
| ARMISTICE CAPITAL, LLC | 1,958,702 | $16M | +48,864 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 1,885,503 | $15M | -38,699 | 2026-06-30 | Filing |
| Parkman Healthcare Partners LLC | 1,807,621 | $14M | +86,357 | 2026-06-30 | Filing |
| ALGERT GLOBAL LLC | 1,742,942 | $14M | +585,984 | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 1,597,749 | $13M | +153,132 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,594,072 | $13M | -19,578 | 2026-06-30 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 1,540,985 | $12M | +146,609 | 2026-06-30 | Filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,492,367 | $12M | +132,710 | 2026-06-30 | Filing |